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Cancer activists who participate with cancer researchers in shaping public health policy provide a
different perspective on the question of breast cancer etiology. We place a higher priority on
reducing women's exposure to suspected breast carcinogens than in debating the specific
biochemical mechanisms by which these agents may operate. As the fruits of AIDS activism and
antismoking campaigns illustrate, answers to mechanistic questions have not been and should
not be the driving force behind public health policy. As such, cancer activists embrace a form of
conservatism that advocates prudence in the face of exposure to estrogenic and other endocrine-
disrupting chemicals. This perspective stands in contrast to scientific conservatism, which directs
its caution toward the issue of proof. Unmet needs for cancer activists refer not so much to data
gaps as to the failure to eliminate ongoing cancer hazards. For this author and activist, unmet
needs include ending women's continued exposure to such common estrogenic compounds as
detergents, triazine herbicides, plastics, and polychlorinated biphenyls. Environ Health
Perspect 105(Suppl 3):685-687 (1997)
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When we in the cancer activist community
look at breast cancer research, we are inter-
ested not only in results, sample size, ele-
gance ofexperimental design, or validity of
the conclusions based on the data. We are
also interested in-and are most interested
in-savingwomen's lives. Therefore, we are
interested in understanding how particular
lines ofscientific inquiry are chosen for
funding and intellectual pursuit, and we are
interested in influencing those choices. We
are interested in how public health policy is
made in the face ofscientific uncertainty.
We are interested in research that identifies
This paper was presented in part at the Workshop on
Hormones, Hormone Metabolism, Environment, and
Breast Cancer held 28-29 September 1995 in New
Orleans, Louisiana. Manuscript received at EHP6 June
1996; manuscript accepted 10 September 1996.
This work was supported by a fellowship in
women's health policy from the Center for Research
on Women and Gender at the University of Illinois,
Chicago, IL.
For information on PVC-free hospitals, contact
Michael Lerner, Director, Commonweal, P.O. Box
316, Bolinas, CA 94924 or Robert Musil, Director,
Physicians for Social Responsibility, 1101 14th Street
NW, Suite 700, Washington, DC 20005.
Address correspondence to Dr. S. Steingraber,
Women's Community Cancer Project, 46 Pleasant
Street, Cambridge, MA 02139. Telephone: (617) 354-
9888. Fax: (617) 666-4725.
Abbreviations used: APEOs, alkylphenol poly-
ethoxylates; NAPBC, National Action Plan on Breast
Cancer; PCBs, polychlorinated biphenyls; PVC,
polyvinyl chloride.
breast carcinogens, and we are interested in
social changes that could keep those agents
out ofwomen's breasts in the first place. In
short, when researchers and activists meet
(for example, as members ofthe National
Action Plan on Breast Cancer [NAPBC]),
activists bring to the table a particular per-
spective on the role ofscience, the direction
it travels, and its methodologies.
Consider the issue of unmet needs,
which members ofthe NAPBC's etiology
working group are requested to address. To
a scientist, an unmet need may represent a
data gap within his or her area ofexpertise.
To an activist, an unmet need may refer to
life without a breast cancer diagnosis. In
the context of estrogenic chemicals and
their relationship to breast cancer, I have
my own personal list ofunmet needs.
Learning how to clean clothes without
the use of estrogenic detergents is an
unmet need. Household detergents, as well
as paints and pesticides, contain estrogenic
alkylphenol polyethoxylates (APEOs).
Since their introduction as chemical surfac-
tants in the 1940s, APEOs have become
widely disseminated in rivers, lakes, and
streams, and therefore in drinking water.
In 1994, researchers in England discovered
that APEOs, in trace amounts, can stimu-
late the growth ofbreast cancer cells (1).
Findingways to keep weeds out ofcorn
fields without the use oftriazine herbicides
is an unmet need. Classified as a possible
human carcinogen, the chloroplast-
destroying triazines have been used since
the 1950s. Theyhave been detected in rain-
drops in 23 states in the upper Midwest
and northeast United States, including pris-
tine areas such as Isle Royale National Park
in northern Minnesota, and they gain
entry into our bodies as contaminants of
drinking water and as residues on food. At
least one of the triazines, atrazine, is a
known endocrine disrupter and is restricted
for use in Germany, the Netherlands, and
several Nordic countries. However, in the
United States, atrazine is used on about
73% of all corn fields. Atrazine causes
mammary gland cancer in at least one strain
oflaboratory rat (2). It also causes chromo-
somal breakage in the tissues ofhamster
ovaries at concentrations below its maxi-
mum legal limit in drinking water (3).
Case-control studies in northern Italy show
a connection between exposure to triazine
herbicides and ovarian cancer among
women farmers (4,5). Triazine weed killers
in the Corn Belt states where I grew up can
reach breathtaking levels in rivers and
streams, and in the finished drinking water
drawn from these sources, during the spring
months ofplantingand rain (6).
Discovering substitutes for polyvinyl
chloride (PVC) plastic is an unmet need.
Vinyl chloride, the industrial feedstock of
PVC, is considered a known human car-
cinogen because ofits link to a rare form of
liver cancer (7). A 1977 study showed that
women who breathe vinyl chloride vapors
on the job showed a 36% excess in breast
cancer mortality (8). Inhalation ofvinyl
chloride as well as ingestion of PVC dust
triggers breast cancer in female rats even at
the lowest doses (9). Freshwater fish con-
tain residues of vinyl chloride as does
drinkingwater, both because vinyl chloride
is a frequent contaminant ofgroundwater
and because PVC water pipes can shed
vinyl chloride from their interior surfaces.
Vinyl chloride vapors also waft from haz-
ardous waste sites and are an important air
pollutant (7,10). It is time to phase out
vinyl chloride.
PVC also contains phthalate plasticiz-
ers, which demonstrate estrogenic proper-
ties. Traces ofphthalates can be found in
food where, like vinyl chloride monomers,
they have migrated from their plastic pack-
aging (11). Ironically, women cancer
patients mayhave higher exposures to vinyl
chloride and phthalates than the general
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population; hospitals are full of PVC
products, including the equipment used
for blood transfusions and intravenous
drips. Are cancer patients receiving breast
carcinogens by direct entry into the blood-
stream even as they are being treated for
their disease? Recent interest in developing
a healthy hospitals campaign that would
address such issues is circulating among
cancer activists and progressive health
care professionals.
A plan to recall, recapture, and contain
polychlorinated biphenyls (PCBs) is an
unmet need. Invented in 1929 and banned
in 1978, PCBs are the elders of the syn-
thetic organochlorine family. Preliminary
research has linked these electrical insula-
tors to breast cancer, and wildlife research
reveals their potential for endocrine disrup-
tion (12). When painted on the eggs of
certain turtle species, PCBs turn male
embryos into females. Moreover, they have
the power to do so at very low concentra-
tions-levels that are comparable to the
average level of PCBs now found in the
breast milk ofwomen living in industrial-
ized countries (13). Of the 209 possible
PCB configurations, some appear to be
estrogenic and some not. We could decide
to funnel resources toward deciphering
which congeners belong in which category,
or we could decide to fund a campaign to
recapture them, thus preventing additional
PCBs from entering our food chain. Only
about one-third of the world's total pro-
duction of PCBs is believed to have
escaped into the general environment. Like
thousands oftiny bombs exploding in slow
motion, pieces of discarded equipment
containing the oily fluid (electrical trans-
formers, television sets, old french fryers)
leak their contents drop by drop into the
soil and water. From there, PCB molecules
rise into the atmosphere, circulate with the
wind, and are redeposited all over the
globe. They then enter the food chain
(14,15). We could very well save more
women's lives by allocating money to get
PCBs out of landfills than we could by
continuing to debate the specific pathways
by which estrogenic chemicals such as
PCBs are metabolized. The impossibility of
quantifying the precise numbers ofbreast
cancer deaths due to PCBs, or any other
suspected breast carcinogen, should not
deter us from the task. Recognizing that
cancer is a multicausal disease with inter-
locking risk factors, breast cancer activists
follow ecologist Rachel Carson's lead in
arguing that a substantial reduction in the
total load ofchemical carcinogens to which
we are all exposed would prevent consid-
erable numbers of cancer diagnoses and
cancer deaths (16).
This brings me to the issue ofmecha-
nisms and proof. The NAPBC, it seems to
me, spends a great deal oftime and energy
on the topic ofgenetic and biochemical
mechanisms ofcarcinogenesis. While I am
as fascinated as any other biologist at the
exquisite nexus of interactions among
chemical metabolites, cellular receptors,
and DNA, I contend that public health
policy has not and should not be driven by
the answers to mechanistic questions.
When we become concerned about hand-
gun violence in the cities in which we live,
we do not need to understand everything
about the ballistics of bullets in order to
take preventive action. When we become
concerned about children's exposure to
lead, we do not need to describe every link
in the biochemical chain between blood
levels and lowering of IQ in order to
demand an end to lead additives in gaso-
line and a remediation oflead-based paint
in housing. When we need to protect our-
selves against AIDS, we do not need to
know everything about CD4 receptor mol-
ecules or cofactor fusin proteins before
learning how to use condoms. Indeed, safe
sex education and needle exchange dramat-
ically lowered HIV infection rates among
certain key populations years before scien-
tists identified the mechanisms by which
the AIDS virus gains entry into human
immune cells. Thousands more lives would
have been lost hadwe waited to take action
until all the viral mechanisms ofinfection
were elucidated. Breast cancer prevention
efforts need to take a lesson from the suc-
cesses ofAIDS activism. (Ironically, the
focus on AIDS prevention has been facili-
tated in part by the incurable nature ofthe
disease. By contrast, breast cancer preven-
tion efforts have historically been overshad-
owed by the glamor ofseeking a cure, and
more recently, by the fatalistic focus on
earlydetection.)
The issue of mechanisms is closely
allied with the issue ofproof. Here, scien-
tists and activists bring two different types
of conservatism to the topic of cancer
research. As argued brilliantly by science
historian Robert Proctor, scientists are con-
servative when they take care not to over-
estimate a hazard or when they speak
cautiously when making statements of
fact. What is being conserved here is the
existing body of scientific knowledge, as
well as the reputation of the speaker.
Cancer activists, on the other hand, tend
to embrace the brand of conservatism
practiced within the field ofpublic health:
prudence for us means acting to reduce
cancer hazards even in the face ofincom-
plete scientific knowledge. In the words of
Proctor, "to do otherwise, to wait and see,
to delay in the face ofgood but partial evi-
dence, is tantamount to experimenting on
humans" (17).
This second definition ofconservatism
was certainly the driving force behind the
decision to criminalize secondhand smoke.
Ofthe 30 studies investigating its connec-
tion to lung cancer, only 9 showed statisti-
cally significant risks; 6 showed no risk at
all or negative risks. Despite the negative
studies and despite the fact that the mech-
anisms behind tobacco's ability to cause
lung cancer are still not well understood,
the U.S. Environmental Protection Agency
declared environmental tobacco smoke a
known human carcinogen (18). Changes
in public policy quickly followed. Tireless
efforts by antismoking activists played as
much a role in codifying our right to
smoke-free airplanes, restaurants, hospi-
tals, and work places as the results of
scientificstudy.
Many breast cancer activists have been
inspired by this kind ofweight-of-the-
evidence approach to environmental health
problems. In considering what kind ofcri-
teria should be used for regulating known
and suspected breast carcinogens, we are
additionally inspired by akeyprinciple that
has emerged from the field ofenvironmen-
tal ethics. This is the precautionary princi-
ple, which dictates that indication ofharm,
rather than proofofharm, should be the
trigger for action (19). By contrast, our cur-
rent system ofregulation appears governed
by what some ofus have referred to as "the
dead body approach," which waits until
damage is proven before action is taken.
"'We need more study' is the grand-
father ofall arguments fortaking no action,"
warns Peter Infante, director ofthe Health
Standards Program at the Occupational
Safety and Health Administration (20). As
we go forward, activists and scientists
together, we must debate the question of
what constitutes sufficient evidence to
advocate public health action even as we
advocate for more research into the ques-
tion of how exactly the metabolism of
endogenous estrogens and xenoestrogenic
chemicals contributes to rising breast
cancer incidence (21).
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